Group 2:200mg catalpol tablets
Sponsors
The First Affiliated Hospital, Zhejiang University
Conditions
diabetes
Phase 1
A single-center, randomized, double-blind, placebo-controlled, dose escalation study to observe the safety and efficacy of catalpol tablets in Chinese healthy subjects.
RecruitingChiCTR1900028589
Start: 2019-12-25Updated: 2020-01-06
A single-center, randomized, double-blind, placebo-controlled, dose escalation study to observe the safety and efficacy of catalpol tablets in Chinese healthy subjects.
RecruitingITMCTR1900002878
Start: 2019-12-25Updated: 2023-02-20